Biotechnology

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

Patenting Antibody and Cell Therapies – What to Do and What Not to Do

By Joanna Applequist, Louise Jonshammar, Niklas Mattsson | Posted on September 28, 2020

Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is...

Tags: antibodies, Biotechnology, cell therapies, EPO, Litigation, patents

Recent contributors

Ashley Zhao

Ashley Zhao

Partner, Attorney at Law, Business Area Manager

Alexandre Theodorou

Alexandre Theodorou

Partner, European Patent Attorney

Troels Peter Rørdam

Troels Peter Rørdam

Senior Counsel, European Patent Attorney

Ylva Strandberg

Ylva Strandberg

Counsel, AU and NZ Patent Attorney

Hongyue Li

Hongyue Li

Senior Associate, China Patent Attorney

Laura Stravinskaite

Laura Stravinskaite

Senior Associate, Attorney at Law